Animal Drugs Market Size By Product (Drugs {Antiparasitic, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines [MLV], Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals}, By Animal Type (Livestock Animals {Poultry, Swine, Cattle, Fish}, Companion Animals {Dogs, Cats, Horses}), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacy and Drug Stores, E-commerce), Industry Analysis Report, Regional, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Industry trends

Animal Drugs Market size surpassed USD 29 billion in 2018 and is expected to achieve over 4.9% CAGR up to 2025. Animal health industry includes veterinary services, vaccines, medical devices, animal drugs and supplies for both companion and production animals. From past few years, prominent pharma players are emphasizing on developing healthcare products for companion animals. Moreover, the animal sector has witnessed technological advances and scientific innovations such as anti-neoplastic veterinary drugs and genomic tests among others. 
 

Get more details on this report - Request Free Sample PDF
 

The animal health market value is booming at a significant rate across the globe. Different factors such as increasing demand for animal drugs with government support for pet care fosters business growth. Furthermore, availability of different animal drugs such as antiparasitic, anti-inflammatory and anti-infectives used to manage animal health effectively should propel the industry growth.
 

Increasing demand for pet insurance schemes across the globe will surge the market demand for animal drugs

Surging demand for pet insurance and growing pet adoption across the globe drive the market growth through 2025. Several pet insurance policies cover a certain part of the body damage or entire body damage for expensive animal drugs and procedures. Different organizations and insurance companies invest in introducing secured animal insurance plans, thereby, augment animal drugs industry progress. However, high cost associated with animal drugs coupled with increasing zoonotic diseases might restrict the market expansion during the analysis period.
 

Vaccines efficiently treat animal diseases that proves beneficial for the segmental progress

Animal vaccines market accounted for around USD 7 billion in 2018. The segment includes modified live vaccines and killed inactivated vaccines among others. Animal vaccines are stored at an appropriate temperature, if not it can lose the effectiveness or potency. These vaccines are regulated by the U.S. Department of Agriculture and Centre for Veterinary Biologics. Growing availability of live and killed inactivated vaccines will favour the segmental growth.
 

Increasing demand for animal protein will provide lucrative market growth opportunities

Based on animal type, the market is fragmented into livestock animals and companion animals. Livestock animals covers poultry, swine, cattle, fish among others, and is accounted for more than 60% animal drugs market share in 2018. The segmental progress is attributed to surged adoption of animal protein-based diets and need to maximize the production from livestock animals. Moreover, livestock farming practices have shifted towards intensive animal farming known as factory farming that increases the yield of several commercial outputs.
 

Oral dosage is least painful as compared to injectables that should propel the segmental growth

The oral administration segment accounted for more than USD 7 billion in 2018. The oral route of administration is commonly used in both livestock and companion animals. Suspensions, solutions, capsules, as well as tablets forms of animal drugs are administrated orally in cattle, pigs, and poultry to improve their health conditions and production. Various benefits associated with oral animal drugs such as least pain, requires no skin penetration and reduced risk for acquiring infections surges demand for oral dosage. 
 

Affordable health treatments at veterinary hospitals will contribute to the business growth

Get more details on this report - Request Free Sample PDF
 

Veterinary hospitals market is projected to witness around 4% CAGR. These hospitals provide several insurance plans with maximum coverage schemes for better diagnosis of animals. Additionally, benefits offered such as corrective health treatments, quality treatment, early detection of disease, affordable and preventive healthcare, favours the segmental growth. 
 

Favorable reimbursement policies for animal health should foster the market progress

Get more details on this report - Request Free Sample PDF
 

North America will witness around 4% CAGR owing to a surging incidences of animal diseases in the region. Further, Regional growth can be attributed to strong foothold of industry players as well as veterinary hospitals, clinics and drug stores. North America Pet Health Insurance Association is one of the major government organization that collectively works with insurance providers and professionals that will drive the market growth. 
 

U.S. animal drugs market share accounted for over USD 10 billion in 2018, owing to favourable reimbursement policies for animal drugs. Presence of various organizations and associations working towards securing animal health should foster the country growth. Additionally, surging demand for insurance of exotic breeds of dogs and cats should propel the market demand.
 

Industry players implement several organic and in-organic strategies to capitalize on thegrowth opportunities

Some of the prominent players operating in veterinary drugs market share are Bayer, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, Elanco, Merck, Virbac and Zoetis. These eminent market players strategically execute various in-organic growth strategies to sustain market competition.
 

Some of the recent industry developments:

• In December 2018, Bayer Animal Health partnered with ParaTheraTech, Inc. for advancement of cryptosporidiosis treatment for farm animals. This partnership enabled Bayer to cater to the growing needs of its customers and strengthened its market presence.
   
• In November 2016, Bimeda, Inc. acquired Ceva Animal Health. This acquisition was a major milestone in Bimeda’s expansion in the equine market.
   

The animal drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:
 

Market Analysis By Product

• Drugs
  • Antiparasitic
  • Anti-inflammatory
  • Anti-infectives
  • Others
• Vaccines
  • Modified live vaccines (MLV)
  • Killed inactivated vaccines
  • Others
• Medicated feed additives
  • Antibiotics
  • Vitamins
  • Amino acids
  • Enzymes
  • Antioxidants
  • Prebiotics and probiotics
  • Minerals
  • Others

By Animal Type

• Livestock animals
  • Poultry
  • Swine
  • Cattle
  • Fish
  • Others
• Companion animals
  • Dogs
  • Cats
  • Horses
  • Others

By Route of Administration

• Oral
• Injectable
• Topical
• Others

By Distribution Channel

• Veterinary hospitals
• Veterinary clinics
• Pharmacy and drug stores
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • The Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • GCC Countries
  • Israel